Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein

Environmental Research

Volumn 110, Issue 1, 2010, Pages 79-82

  Everett, Charles J ^a   King, Dana E ^a   Player, Marty S ^a   Matheson, Eric M ^a   Post, Robert E ^a   Mainous III, Arch G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

C reactive protein; Inflammation; Monohydroxy polycyclic aromatic hydrocarbons

Indexed keywords

2 HYDROXYPHENANTHRENE; 9 FLUORENOL; C REACTIVE PROTEIN; CREATININE; POLYCYCLIC AROMATIC HYDROCARBON; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; UNCLASSIFIED DRUG;

BODY MASS; CARDIOVASCULAR DISEASE; CONCENTRATION (COMPOSITION); DEMOGRAPHIC SURVEY; GENDER; HEALTH STATUS; HEALTH SURVEY; HYPERTENSION; LOGISTICS; PAH; PROTEIN; RACE; REGRESSION ANALYSIS; SMOKING; URINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEALTH SURVEY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNITED STATES; URINALYSIS; URINE LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ENVIRONMENTAL POLLUTANTS; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYCYCLIC HYDROCARBONS, AROMATIC; SERUM; UNITED STATES; YOUNG ADULT;

NORTH AMERICA; UNITED STATES;

EID: 71249138870     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2009.09.010     Document Type: Article

References (36)

1. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Polycyclic Aromatic Hydrocarbons (1995), US Department of Health and Human Services, Public Health Service, Atlanta, GA. http://www.atsdr.cdc.gov/toxprofiles/tp69.html (cited 2009 January 25). Available from URL: 〈http://www.atsdr.cdc.gov/toxprofiles/tp69.htm〉
2. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition Examination Survey, NHANES 2003-2004. Laboratory Procedure Manual: C-Reactive Protein. 2000 (cited 2009 January 30). Available from URL: 〈http://www.cdc.gov/nchs/ about/major/nhanes/nhanes2003-2004/lab_methods_03_04.htm〉
3. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition Examination Survey, NHANES 2003-2004. Laboratory Procedure Manual: Monohydroxy-Polycyclic Aromatic Hydrocarbons (OH-PAHs). 2006 (cited 2009 January 30). Available from URL: 〈http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/lab_methods_03_04.htm〉
4. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Health and Nutrition Examination Survey, NHANES 2003-2004. 2009 (cited 2009 January 30). Available from URL: 〈http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/nhanes03_04.htm〉
5. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann. Intern. Med. 145 (2006) 21-29
6. Cummings D.M., King D.E., Mainous III A.G., and Geesey M.E. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 180-185
7. Curb J.D., Abbott R.D., Rodriguez B.L., Sakkinen P., Popper J.S., Yano K., and Tracy R.P. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107 (2003) 2016-2020
8. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Gallimore J.R., and Pepys M.B. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 7255 (2000) 199-204
9. Environment Canada. Ambient air measurements of polycyclic aromatic hydrocarbons (PAH), polychlorinated dibenzo-p-dioxins (PCDD) and polychlorinated dibenzofurans in Canada (1987-1997). Environmental Technology Center Report, 2007 (cited 2008 August 3). Available from URL: 〈http://www.etc-cte.ec.gc.ca/publications/recent/pah_report_e.html〉
10. Erbel R., Mohlenkamp S., Lehmann N., Schmermund A., Moebus S., Stang A., Gronemeyer D., Seibel R., Mann K., Volbracht L., Dragano N., Siegrist J., and Jockel K.H. Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis 197 (2008) 662-672
11. Grainger, J., Huang, W., Patterson Jr., D.G., Turner, W.E., Pirkle, J., Caudill, S.P., Wang, R.Y., Needham, L.L., Sampson, E.J., 2006. Reference range levels of polycyclic aromatic hydrocarbons in the US population by measurement of urinary monohydroxy metabolities. Environ. Res. 100, 394-423.
12. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
13. Hansson G.K., and Nilsson J. Introduction: atherosclerosis as inflammation: a controversial concept becomes accepted. J. Intern. Med. 263 (2008) 462-463
14. Jacob J., and Seidel A. Biomonitoring of polycyclic aromatic hydrocarbons in human urine. J. Chromatogr. B 778 (2002) 31-47
15. King D.E., Mainous III A.G., Egan B.M., Woolson R.F., and Geesey M.E. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care 28 (2005) 1487-1489
16. King D.E., Mainous III A.G., Egan B.M., Woolson R.F., and Geesey M.E. Effect of psyllium fiber supplementation on C-reactive protein: The Trial to Reduce Inflammatory Markers (TRIM). Ann. Fam. Med. 6 (2008) 100-106
17. Li Z., Romanoff L.C., Trinidad D.A., Hussain N., Jones R.S., Porter E.N., Patterson Jr. D.G., and Sjodin A. Measurement of urinary monohydroxy polycyclic aromatic hydrocarbons using automated liquid-liquid extraction and gas chromatography/isotope dilution high-resolution mass spectrometry. Anal. Chem. 78 (2006) 5744-5751
18. Li, Z., Sandau, C.D., Romanoff, L.C., Caudill, S.P., Sjodin, A., Needham, L.L., Patterson Jr., D.G., 2008. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ. Res. 107, 320-331.
19. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
20. Mega J.L., Morrow D.A., Cannon C.P., Murphy S., Cairns R., Ridker P.M., and Braunwald E. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. J. Thromb. Thrombolysis 22 (2006) 71-76
21. Park R., Detrano R., Xiang M., Fu P., Ibrahim Y., LaBree L., and Azen S. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106 (2002) 2073-2077
22. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., and Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
23. Peters A., Frohlich M., Doring A., Immervoll T., Wichmann H.-E., Pepys M.B., and Koenig W. Particulate air pollution is associated with an acute phase response in men: results from the MONICA-Augsburg study. Eur. Heart J. 22 (2001) 1198-1204
24. Ramesh A., Walker S.A., Hood D.B., Guillen M.D., Schneider K., and Weyand E.H. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int. J. Toxicol. 23 (2004) 301-333
25. Research Triangle Institute. SUDAAN: Version 9.0.1 for SAS Version 9. Research Triangle Institute. Research Triangle Park, North Carolina; 2005.
26. Ridker P.M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49 4 (2007) 2129-2138
27. Ridker P.M. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin. Chem. 55 2 (2009) 209-215
28. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997) 973-979
29. Ridker P.M., Danielson E., Fonseca F.A.H., Genest J., Gotto Jr. A.M., Kastelein J.J.P., Koenig W., Libby P., Lorenzatti A.J., MacFadyen J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., and Glynn R.J. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359 (2008) 2195-2207
30. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
31. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347 (2002) 1557-1565
32. Romanoff L.C., Li Z., Young K.J., Blakely N.C., Patterson Jr. D.G., and Sandau C.D. Automated solid-phase extraction method for measuring urinary polycyclic aromatic hydrocarbon metabolites in human biomonitoring using isotope-dilution gas chromatography high-resolution mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 835 (2006) 47-54
33. Schauer C., Niessner R., and Poschl U. Polycyclic aromatic hydrocarbons in urban air particulate matter: decadal and seasonal trends, chemical degradation, and sampling artifacts. Environ. Sci. Technol. 37 (2003) 2861-2868
34. Scherer G., Frank S., Riedel K., Meger-Kossien I., and Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 373-380
35. Schillinger M., Exner M., Miekusch W., Sabeti S., Amighi J., Nikowitsch R., Timmel E., Kickinger B., Minar C., Pones M., Lalouschek W., Rumpold H., Maurer G., Wagner O., and Minar E. Inflammation and carotid artery-risk for atherosclerosis study (ICARAS). Circulation 111 (2005) 2203-2209
36. Vigushin D.M., Pepys M.B., and Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J. Clin. Invest. 90 (1993) 1351-1357